Tokyo, Oct. 3 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063149) titled 'Population-Based Ophthalmic Screening in Taku-shima Island, Hirado, Japan' on Oct. 2.
Study Type:
Observational
Primary Sponsor:
Institute - LIME Working Group
Condition:
Condition - Ocular diseases and ocular surface disorders, including meibomian gland dysfunction and dry eye disease
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - The purpose of this study is to conduct ophthalmic screening among residents of Taku-shima Island, Hirado City, Nagasaki Prefecture, where no ophthalmologist is permanently available, to facilitate the early detection of ocular diseases and to promote awareness of eye health and ocular diseases.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 6
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Residents aged 6 years or older living on Taku-shima Island, Hirado City, Nagasaki Prefecture, Japan, who provided informed consent to participate in the study themselves or through a legally authorized representative.
Key exclusion criteria - Individuals who do not provide informed consent to participate in the study or who are considered by the investigator to be unable to undergo the study examinations.
Target Size - 500
Recruitment Status:
Recruitment status - Completed
Date of protocol fixation - 2025 Year 02 Month 20 Day
Date of IRB - 2025 Year 02 Month 21 Day
Anticipated trial start date - 2025 Year 03 Month 28 Day
Last follow-up date - 2026 Year 10 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072278
Disclaimer: Curated by HT Syndication.
